Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|
BALYASNY ASSET MANAGEMENT L.P. | 9.99% | +7.67% | $52.5M | $8.98M | 5.78M | +20.7% | Balyasny Asset Management L.P. | Jun 30, 2025 |
RTW INVESTMENTS, LP | 9.9% | +20% | $51.1M | $12.5M | 5.63M | +32.5% | RTW Investments, LP | Jun 30, 2025 |
Nantahala Capital Management, LLC | 9.99% | 0% | $25.3M | $4.34M | 5.46M | +20.7% | Nantahala Capital Management, LLC | Mar 31, 2025 |
Logos Global Management LP | 6.2% | $25.6M | 3.43M | Logos Global Management LP | Jul 21, 2025 | |||
VANGUARD GROUP INC | 6.23% | +30.4% | $25.5M | $7.41M | 3.42M | +40.9% | The Vanguard Group | Jun 30, 2025 |
Soleus Capital Master Fund, L.P. | 7.3% | $15.5M | 3.35M | Soleus Capital Management, L.P. | Dec 31, 2024 | |||
Point72 Asset Management, L.P. | 6.1% | $24.9M | 3.34M | Point72 Asset Management, L.P. | Jul 25, 2025 | |||
Stonepine Capital Management, LLC | 5% | +4% | $21.1M | $4.7M | 2.83M | +28.6% | Stonepine Capital Management, LLC | Jul 22, 2025 |
BlackRock, Inc. | 4.9% | $11.7M | 2.52M | BlackRock, Inc. | Mar 31, 2025 | |||
BIOTECHNOLOGY VALUE FUND L P | 3.9% | -60.9% | $22.7M | -$29.2M | 2.5M | -56.3% | BVF PARTNERS L P/IL | Aug 11, 2025 |
HIRSCHMAN ORIN | 3.6% | -41.7% | $14.9M | -$5.33M | 2M | -26.3% | Orin Hirschman | Jun 30, 2025 |
ORBIMED ADVISORS LLC | 2.4% | -53.3% | $12.1M | -$13.9M | 1.33M | -53.4% | ORBIMED ADVISORS LLC | Jun 30, 2025 |
Alyeska Investment Group, L.P. | 2.1% | $4.64M | 1M | Alyeska Investment Group, L.P. | Dec 31, 2024 | |||
Soleus Private Equity Fund III, L.P. | 1.8% | $4.34M | 936K | Soleus Capital Management, L.P. | Mar 31, 2025 |
Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
---|---|---|---|---|---|
2025 Q3 | 62 | $547 | -$53.8K | $8.82 | 1 |
2025 Q2 | 52.6M | $218M | +$27M | $4.15 | 108 |
2025 Q1 | 43.3M | $261M | +$53M | $6.03 | 98 |
2024 Q4 | 33.9M | $175M | +$45.2M | $5.17 | 90 |
2024 Q3 | 26.6M | $80.4M | +$34.2M | $2.99 | 77 |
2024 Q2 | 14.5M | $43.3M | -$62.7M | $2.98 | 66 |
2024 Q1 | 16.9M | $199M | +$4.6M | $11.80 | 69 |
2023 Q4 | 16.7M | $136M | -$1.64M | $8.14 | 56 |
2023 Q3 | 16.7M | $136M | +$6.64M | $8.13 | 55 |
2023 Q2 | 16.1M | $120M | +$120M | $7.44 | 59 |